Trial Profile
Efficacy of simvastatin for the prevention of cardiovascular disorders in high-risk patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Nov 2011
Price :
$35
*
At a glance
- Drugs Simvastatin (Primary)
- Indications Cardiovascular disorders
- Focus Therapeutic Use
- Acronyms HPS
- 21 Mar 2011 Results of a pharmacogenomics substudy published in the Journal of the American College of Cardiology.
- 05 Nov 2010 New trial record.